Systemic Reactions to SCIT: Effects of Dosing and Aeroallergen Content

Document Type

Poster Presentation

Publication Date

11-2018

Abstract

Introduction

The aim of this study was to identify the dose of subcutaneous immunotherapy (SCIT) that caused the most systemic reactions (SCITSR), and identify any other risk factors for SCITSR.

Methods

We performed a retrospective review of all SCIT encounters from 2013-2017 at a multi-site Allergy/Immunology practice. SCIT was administered in doses consistent with practice parameters. SCITSR were identified through immunotherapy encounters in which epinephrine was administered. Collected data included patient demographics, along with the dose of SCIT at time of the SR, the presence or absence of asthma, and aeroallergen content. The control group was generated randomly from the same cohort during the same time period.

Results

There were 86,949 SCIT visits, with 81 SCITSR (0.9/1000). 77.8% of reactions occurred at dose of 1:1 0.1 ml and above. The presence of cat (81.5% vs. 63%, p=.014), dog (67.9% vs. 37.0%, p

Conclusions

Risk factors for SCITSR in a multisite Allergy/Immunology practice included administration of the highest immunotherapy doses, inclusion of cat, dog, and grass extracts, and the number of aeroallergenic groups included in the extract. This information helps further characterize risk for patients receiving SCIT.

Comments

Presented at the 2018 Annual Scientific Meeting of the American College of Allergy, Asthma & Immunology, Seattle, Washington, November 15-19, 2018.

Abstract published in Annals of Allergy, Asthma & Immunology, Volume 121,Issue 5, Supplement, s27.

https://www.annallergy.org/article/S1081-1206(18)30828-7/abstract

This document is currently not available here.

Additional Files

Share

COinS